Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-21-000017

Chief Scientific Officer acquired 38,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kishimoto Takashi Kei · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2021-01-04 Grant or award : show line 1 in the form +38,000 164,149 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-01-04 Grant or award : show line 2 in the form Employee Stock Option (right to buy) +230,000 $2.99 2031-01-03 230,000 230,000 D
Loading xslF345X03/wf-form4_160996979617224.xml…